About | Iambic Therapeutics

ABOUT US

Drug discovery driven by people, amplified by AI

Fred Manby & Tom Miller, Co-Founders

Tom Miller, PhD

Co-Founder and Chief Executive Officer

Fred Manby, PhD

Co-Founder and Chief Technology Officer

Neil Josephson, MD

Chief Medical Officer

Pete Olson, PhD

Chief Scientific Officer

Michael Secora, PhD

Chief Financial Officer and Chief Corporate Development Officer

Laurent Gomez, PhD

Senior Vice President and Head of Discovery

Matt Welborn, PhD

Senior Vice President, Machine Learning

Sunny Chang, JD

General Counsel

Tom Miller, PhD

Co-Founder and Chief Executive Officer

Fred Manby, PhD

Co-Founder and Chief Technology Officer

Kurt von Emster

Samit Hirawat, MD

Evan Rachlin, MD

Ascenta Capital

William Rastetter, PhD

Board Member

Mary Tagliaferri, MD

Jacob Vogelstein, PhD

Catalio Capital

Alex A. Adjei, MD

Chair of Taussig Cancer Institute, Cleveland Clinic

Anima Anandkumar, PhD

Professor of Computing and Mathematical Sciences, Caltech, Former Senior Director of AI at NVIDIA

Frances Arnold, PhD

Nobel Laureate, Professor of Chemical Engineering, Bioengineering and Biochemistry, Caltech

Ken Brameld, PhD

Former Head of Research, Principia Biopharma, Co-founder, Alumis, Inc.

Former President of Global Research and Early Development, Celgene Corporation

Ray Deshaies, PhD

Former Amgen SVP for Global Research

Maria Koehler, MD

PhD, Chief Medical Officer Repare Therapeutics, Former CMO Bicycle Therapeutics, Former VP of Strategy, Innovation and Collaboration, Pfizer Oncology

Derek Lowe, PhD

Novartis Director of Chemical Biology Therapeutics, Author of “In the Pipeline” Blog

Kwok-Kin Wong, MD

MD, Director of Hematology and Medical Oncology, NYU Langone Health

Investors